CSI Market
Sign In | Register

Cen Biotech Inc (CENB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CENB Annual Cash Flow →
A period-by-period view of cash flow from Cen Biotech Inc to Sep 30 2021 helps clarify how Sep 30 2022's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-1.03
Depreciation & amortization0.03
Amortization of Other Assets0.29
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.15
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.01
Noncash Interest Expense Related Party-
Deferred Lease Expense-
Increase Decrease In Operating Lease Right Of Use Asset-
Lease Expense Benefit-
Operating Lease Impairment Loss-
Gain Loss On Termination Of Lease-
Issuance Of Stock Related To Lease Termination Settlement-
Noncash Services Expense-
Fair Value Adjustment Of Aquired Liability-
Stock Issued For Settlement Of Interest0.01
Increase Decrease In Accrued Interest Related And Nonrelated Parties0.19
Increase Decrease In Operating Lease Liability-0.03
Increase Decrease In Governmental Assistance Payable-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.18
Accounts Payable-0.09
Increase (Decrease) in Accrued Liabilities-0.26
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.06
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.01
Discontinued operations0.00
Net Cash flow from Operating Activities-0.51
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments For Leashold Improvements In Process-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Payments to Fund Long-term Loans to Related Parties0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.62
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.31
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.93
Proceeds From Issuance Of Loans Payable Related Party-
Repayments Of Loans Payable Related Party-
Repayments Of Convertible Notes Payable Related Party-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.51
Total Cash Flow-0.04
4 historic quarters locked

Sign in to unlock the full Cen Biotech Inc cash flow history.

Sign In Create Free Account

About Cen Biotech Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-22-027170

Figures are derived from filed reports and may be restated. Historical data is subject to revision.